Kodiak Sciences Inc (KOD)
2.69
-0.12
(-4.27%)
USD |
NASDAQ |
Jun 17, 16:00
2.70
+0.01
(+0.37%)
Pre-Market: 20:00
Kodiak Sciences Free Cash Flow: -175.76M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -175.76M |
| December 31, 2023 | -195.61M |
| September 30, 2023 | -196.58M |
| June 30, 2023 | -223.95M |
| March 31, 2023 | -251.84M |
| December 31, 2022 | -253.82M |
| September 30, 2022 | -263.02M |
| June 30, 2022 | -286.32M |
| March 31, 2022 | -265.61M |
| December 31, 2021 | -245.57M |
| September 30, 2021 | -207.84M |
| Date | Value |
|---|---|
| June 30, 2021 | -150.36M |
| March 31, 2021 | -113.72M |
| December 31, 2020 | -90.43M |
| September 30, 2020 | -69.71M |
| June 30, 2020 | -51.39M |
| March 31, 2020 | -50.48M |
| December 31, 2019 | -39.58M |
| September 30, 2019 | -37.00M |
| June 30, 2019 | -34.15M |
| March 31, 2019 | -25.57M |
| December 31, 2018 | -29.03M |
Free Cash Flow Range, Past 5 Years
-286.32M
Minimum
Jun 2022
-34.15M
Maximum
Jun 2019
-160.14M
Average
-185.69M
Median
Free Cash Flow Benchmarks
| Avalo Therapeutics Inc | -26.83M |
| Regeneron Pharmaceuticals Inc | 3.930B |
| Ligand Pharmaceuticals Inc | -19.62M |
| iBio Inc | -18.67M |
| Dare Bioscience Inc | -30.19M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -39.60M |
| Cash from Investing (Quarterly) | -0.166M |
| Cash from Financing (Quarterly) | 0.038M |
| Free Cash Flow Per Share (Quarterly) | -0.7546 |
| Free Cash Flow Yield | -124.6% |